chr11-2405530-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_014555.4(TRPM5):c.3388C>T(p.Arg1130Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00014 in 1,558,768 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_014555.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRPM5 | NM_014555.4 | c.3388C>T | p.Arg1130Trp | missense_variant | 28/29 | ENST00000696290.1 | |
TRPM5 | XM_017017628.2 | c.3466C>T | p.Arg1156Trp | missense_variant | 25/26 | ||
TRPM5 | XM_047426858.1 | c.3442C>T | p.Arg1148Trp | missense_variant | 25/26 | ||
TRPM5 | XM_047426859.1 | c.2263C>T | p.Arg755Trp | missense_variant | 16/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRPM5 | ENST00000696290.1 | c.3388C>T | p.Arg1130Trp | missense_variant | 28/29 | NM_014555.4 | P2 | ||
ENST00000433035.1 | n.319+697G>A | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000716 AC: 12AN: 167592Hom.: 0 AF XY: 0.0000338 AC XY: 3AN XY: 88718
GnomAD4 exome AF: 0.000122 AC: 172AN: 1406578Hom.: 0 Cov.: 32 AF XY: 0.000112 AC XY: 78AN XY: 694510
GnomAD4 genome AF: 0.000302 AC: 46AN: 152190Hom.: 0 Cov.: 33 AF XY: 0.000256 AC XY: 19AN XY: 74336
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 15, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at